JP2011525388A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011525388A5 JP2011525388A5 JP2011514898A JP2011514898A JP2011525388A5 JP 2011525388 A5 JP2011525388 A5 JP 2011525388A5 JP 2011514898 A JP2011514898 A JP 2011514898A JP 2011514898 A JP2011514898 A JP 2011514898A JP 2011525388 A5 JP2011525388 A5 JP 2011525388A5
- Authority
- JP
- Japan
- Prior art keywords
- delivery system
- eye
- latanoprost
- punctal plug
- days
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 25
- GGXICVAJURFBLW-CEYXHVGTSA-N Latanoprost Chemical compound CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1 GGXICVAJURFBLW-CEYXHVGTSA-N 0.000 claims 21
- 229960001160 latanoprost Drugs 0.000 claims 21
- 230000004410 intraocular pressure Effects 0.000 claims 11
- 241000083513 Punctum Species 0.000 claims 10
- 230000002459 sustained Effects 0.000 claims 9
- 239000003814 drug Substances 0.000 claims 7
- 208000010412 Glaucoma Diseases 0.000 claims 6
- 239000003889 eye drop Substances 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 229940079593 drugs Drugs 0.000 claims 3
- 238000009472 formulation Methods 0.000 claims 3
- 150000003180 prostaglandins Chemical class 0.000 claims 3
- 229920002988 biodegradable polymer Polymers 0.000 claims 2
- 239000004621 biodegradable polymer Substances 0.000 claims 2
- 239000011159 matrix material Substances 0.000 claims 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N Epinephrine Chemical class CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 claims 1
- 206010030348 Open angle glaucoma Diseases 0.000 claims 1
- 239000000695 adrenergic alpha-agonist Substances 0.000 claims 1
- 201000002862 angle-closure glaucoma Diseases 0.000 claims 1
- 229940006133 antiglaucoma drugs and miotics Carbonic anhydrase inhibitors Drugs 0.000 claims 1
- 239000002876 beta blocker Substances 0.000 claims 1
- 239000003489 carbonate dehydratase inhibitor Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000000875 corresponding Effects 0.000 claims 1
- 239000006196 drop Substances 0.000 claims 1
- 230000004406 elevated intraocular pressure Effects 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 230000003547 miosis Effects 0.000 claims 1
- 239000003604 miotic agent Substances 0.000 claims 1
- 229920001296 polysiloxane Polymers 0.000 claims 1
- 201000006366 primary open angle glaucoma Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7528408P | 2008-06-24 | 2008-06-24 | |
| US61/075,284 | 2008-06-24 | ||
| PCT/US2009/048452 WO2010008883A1 (en) | 2008-06-24 | 2009-06-24 | Combination treatment of glaucoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011525388A JP2011525388A (ja) | 2011-09-22 |
| JP2011525388A5 true JP2011525388A5 (US20050271705A1-20051208-C00006.png) | 2012-08-02 |
Family
ID=41431875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011514898A Pending JP2011525388A (ja) | 2008-06-24 | 2009-06-24 | 緑内障の併用治療 |
Country Status (7)
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006014434A2 (en) | 2004-07-02 | 2006-02-09 | Eliot Lazar | Treatment medium delivery device and methods for delivery |
| CN103393496B (zh) | 2006-03-31 | 2016-08-17 | 玛提治疗有限公司 | 用于药物治疗的鼻泪引流系统植入物 |
| WO2009035571A2 (en) | 2007-09-07 | 2009-03-19 | Qlt Plug Delivery, Inc | Lacrimal implant detection |
| JP2011520805A (ja) | 2008-05-09 | 2011-07-21 | キューエルティー プラグ デリバリー，インク． | 緑内障および高眼圧症治療のための活性剤の持続送達 |
| EP4108216A1 (en) | 2009-06-03 | 2022-12-28 | Forsight Vision5, Inc. | Anterior segment drug delivery |
| SG187770A1 (en) | 2010-08-12 | 2013-03-28 | Univ Nanyang Tech | A liposomal formulation for ocular drug delivery |
| US8591484B2 (en) | 2010-09-15 | 2013-11-26 | AlphaMed, Inc. | Lacrimal punctum measurement and occlusion |
| US20120312840A1 (en) * | 2011-05-13 | 2012-12-13 | Ayako Hasegawa | Container closure system with integral antimicrobial additives |
| US9974685B2 (en) | 2011-08-29 | 2018-05-22 | Mati Therapeutics | Drug delivery system and methods of treating open angle glaucoma and ocular hypertension |
| ES2727203T3 (es) | 2011-08-29 | 2019-10-14 | Mati Therapeutics Inc | Administración por liberación sostenida de agentes activos para tratar glaucoma e hipertensión ocular |
| RU2740680C2 (ru) | 2011-09-14 | 2021-01-19 | Форсайт Вижн5, Инк. | Глазное вкладочное устройство и способы |
| US9750636B2 (en) | 2012-10-26 | 2017-09-05 | Forsight Vision5, Inc. | Ophthalmic system for sustained release of drug to eye |
| US20140206708A1 (en) * | 2013-01-24 | 2014-07-24 | Rigel Pharmaceuticals, Inc. | Composition for ophthalmic administration |
| US9956195B2 (en) | 2014-01-07 | 2018-05-01 | Nanyang Technological University | Stable liposomal formulations for ocular drug delivery |
| US9424722B2 (en) * | 2014-05-14 | 2016-08-23 | Unlimited Liability, LLC | Smart memory material lock devices |
| RU2562515C1 (ru) * | 2014-08-19 | 2015-09-10 | федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации | Интубационный набор для биканаликулярного дренирования слезоотводящих путей |
| US20170266391A1 (en) * | 2014-09-22 | 2017-09-21 | Kaneka Corporation | Injection needle device for endoscope |
| EP3223793B1 (en) | 2014-11-25 | 2023-06-28 | Eximore Ltd. | Compositions and methods for delivering a bio-active agent or bio-active agents |
| US20160296532A1 (en) | 2015-04-13 | 2016-10-13 | Forsight Vision5, Inc. | Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent |
| US11291847B2 (en) * | 2015-06-16 | 2022-04-05 | The Regents Of The University Of Colorado, A Body Corporate | Systems and methods for preventing, diagnosing, and/or treating one or more medical conditions via neuromodulation |
| CN105879126A (zh) * | 2016-03-24 | 2016-08-24 | 杭州亚慧生物科技有限公司 | 一种超润滑血清白蛋白泪点塞及其制备方法 |
| WO2019191700A1 (en) * | 2018-03-29 | 2019-10-03 | Mati Therapeutics | Ophthalmic drug sustained release formulation and uses for dry eye syndrome treatment |
| CN109568138B (zh) * | 2019-01-10 | 2021-06-25 | 新疆国际旅行卫生保健中心 | 药片分割装置 |
| US11207267B2 (en) | 2019-10-02 | 2021-12-28 | Segal Innovations LLC | Bio-adhesive dissolving compounds and device |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4281654A (en) * | 1980-04-07 | 1981-08-04 | Alza Corporation | Drug delivery system for controlled ocular therapy |
| US5589563A (en) * | 1992-04-24 | 1996-12-31 | The Polymer Technology Group | Surface-modifying endgroups for biomedical polymers |
| DK0637323T3 (da) * | 1992-04-24 | 1999-05-25 | Polymer Technology Group Inc | Copolymerer og ikke-porøs, semipermeabel membran deraf og dens anvendelse til permeering af molekyler med et forudbestemt m |
| US6196993B1 (en) * | 1998-04-20 | 2001-03-06 | Eyelab Group, Llc | Ophthalmic insert and method for sustained release of medication to the eye |
| ES2172415B2 (es) * | 2000-07-28 | 2003-11-16 | Univ Madrid Complutense | Tratamiento del glaucoma y la hipertension ocular por medio de un analogo de la melatonina. |
| US6534693B2 (en) * | 2000-11-06 | 2003-03-18 | Afmedica, Inc. | Surgically implanted devices having reduced scar tissue formation |
| AU2004207506B2 (en) * | 2003-01-24 | 2009-10-08 | Psivida Us Inc. | Sustained release device and method for ocular delivery of adrenergic agents |
| WO2004075781A2 (en) * | 2003-02-26 | 2004-09-10 | Medivas, Llc | Bioactive stents and methods for use thereof |
| US7662864B2 (en) * | 2003-06-04 | 2010-02-16 | Rutgers, The State University Of New Jersey | Solution polymerization processes to prepare a polymer that degrades to release a physiologically active agent |
| US20050129731A1 (en) * | 2003-11-03 | 2005-06-16 | Roland Horres | Biocompatible, biostable coating of medical surfaces |
| US20050232972A1 (en) * | 2004-04-15 | 2005-10-20 | Steven Odrich | Drug delivery via punctal plug |
| US7799336B2 (en) * | 2004-04-30 | 2010-09-21 | Allergan, Inc. | Hypotensive lipid-containing biodegradable intraocular implants and related methods |
| US20070197491A1 (en) * | 2005-10-14 | 2007-08-23 | Alcon, Inc. | Method for treating primary and secondary forms of glaucoma |
| CN103393496B (zh) * | 2006-03-31 | 2016-08-17 | 玛提治疗有限公司 | 用于药物治疗的鼻泪引流系统植入物 |
| JP5323720B2 (ja) * | 2006-12-18 | 2013-10-23 | アルコン リサーチ， リミテッド | 眼用薬物送達のためのデバイスおよび方法 |
| UY30883A1 (es) * | 2007-01-31 | 2008-05-31 | Alcon Res | Tapones punctales y metodos de liberacion de agentes terapeuticos |
| WO2009035567A2 (en) * | 2007-09-07 | 2009-03-19 | Qlt Plug Delivery, Inc | Insertion and extraction tools for lacrimal implants |
| CN101984745B (zh) * | 2007-09-07 | 2013-08-14 | Qlt股份有限公司 | 用于持续释放治疗药物的药物核心 |
| CA2698508C (en) * | 2007-09-07 | 2017-06-06 | Alan R. Rapacki | Lacrimal implants and related methods |
| MX2010008998A (es) * | 2008-02-18 | 2010-11-26 | Qlt Plug Delivery Inc | Implantes lagrimales y metodos relacionados. |
| WO2009134371A2 (en) * | 2008-04-30 | 2009-11-05 | Qlt Plug Delivery, Inc. | Composite lacrimal insert and related methods |
| JP2011520805A (ja) * | 2008-05-09 | 2011-07-21 | キューエルティー プラグ デリバリー，インク． | 緑内障および高眼圧症治療のための活性剤の持続送達 |
-
2009
- 2009-06-24 TW TW098121236A patent/TW201012469A/zh unknown
- 2009-06-24 CN CN2009801288704A patent/CN102105118A/zh active Pending
- 2009-06-24 EP EP09798519.6A patent/EP2303184A4/en not_active Withdrawn
- 2009-06-24 CA CA2728623A patent/CA2728623A1/en not_active Abandoned
- 2009-06-24 US US12/490,923 patent/US20090318549A1/en not_active Abandoned
- 2009-06-24 JP JP2011514898A patent/JP2011525388A/ja active Pending
- 2009-06-24 WO PCT/US2009/048452 patent/WO2010008883A1/en active Application Filing
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011525388A5 (US20050271705A1-20051208-C00006.png) | ||
| NZ588938A (en) | Sustained release delivery of active agents to treat glaucoma and ocular hypertension | |
| JP2011520805A5 (US20050271705A1-20051208-C00006.png) | ||
| CN101888839B (zh) | 治疗眼睛病症的omega-3脂肪酸、羟基多不饱和脂肪酸、脂氧素类化合物或脂氧化物类化合物 | |
| Grob et al. | Management of mydriasis and pain in cataract and intraocular lens surgery: review of current medications and future directions | |
| Yellepeddi et al. | Punctal plug: a medical device to treat dry eye syndrome and for sustained drug delivery to the eye | |
| JP2016028091A5 (US20050271705A1-20051208-C00006.png) | ||
| JP2019532931A (ja) | 眼瞼炎の治療に使用するための医薬組成物 | |
| WO2010085696A3 (en) | Sustained released delivery of one or more agents | |
| JP2008538215A5 (US20050271705A1-20051208-C00006.png) | ||
| Miller et al. | Medical anti‐glaucoma therapy: Beyond the drop | |
| SG170816A1 (en) | Drug delivery methods, structures, and compositions for nasolacrimal system | |
| NZ602445A (en) | Ketorolac tromethamine compositions for treating or preventing ocular pain | |
| WO2012092510A3 (en) | Ocular drug delivery system | |
| ES2649730T3 (es) | Distribución craneal de compuestos farmacéuticos | |
| JP2016121163A (ja) | 眼内でのコルチコステロイド使用に伴う眼圧の発生を減少させる方法 | |
| Pavan-Langston et al. | Boston keratoprosthesis treatment of herpes zoster neurotrophic keratopathy | |
| Li et al. | Chinese expert consensus on perioperative medication in laser corneal refractive surgeries (2019) | |
| Uña et al. | Perioperative pharmacological management in patients with glaucoma | |
| JP2015520628A5 (US20050271705A1-20051208-C00006.png) | ||
| Tan et al. | Ab-externo implantation of XEN gel stent for refractory steroid-induced glaucoma after lamellar keratoplasty | |
| WO2011163356A2 (en) | Methods of treating conditions associated with overactive bladder | |
| Higginbotham | Will latanoprost be the'wonder'drug of the'90s for the treatment of glaucoma? | |
| JP2013129604A (ja) | 緑内障治療薬を含有する徐放性フィルム製剤 | |
| Mirza et al. | INHIBITION OF SURGICALLY INDUCED MIOSIS WITH NEPAFENAC |
